Austrian authorities have stopped vaccinations with AstraZeneca COVID-19 vaccine as a precautionary measure in the wake of a shooting and another illness, a health agency said on Sunday.
“The Federal Office for Health and Safety (BASG) has received two reports of a temporary batch of the same dose of AstraZeneca vaccine at a clinic in the Lower Austrian state of Wetel,” the statement said.
A 49-year-old woman died of severe coagulation disorders, and a 35-year-old woman was diagnosed with pulmonary embolism and is recovering. Pulmonary embolism is an acute lung disease caused by a displaced blood clot.
“There is currently no evidence of a causal link between vaccines,” BASG said.
According to the Swiss newspaper Niederoesterreichische Nachrichten, as reported by ORF գործակալ A news agency, the women are both nurses who worked at the Zwettl clinic.
The BASG said that blood clotting was not one of the known side effects of the vaccine. It vigorously pursued its investigation to completely rule out all possible connections.
“As a precautionary measure, the remaining stocks of the affected vaccine are no longer released or vaccinated,” he added.
AstraZeneca did not immediately comment when contacted.
A news agency quoted AstraZeneca as saying that the company was in contact with the Austrian authorities and would fully support the investigation.
The vaccine was approved by the European Medicines Agency and the World Health Organization, based on a global clinical program involving 23,000 participants.
“All these assessments have led to the conclusion that the AstraZeneca COVID-19 19 vaccine is safe and effective,” the company was quoted as saying by A.
EU regulators proved the product on January 30, saying it was effective and safe to use. The adverse reactions observed in the experiments were mostly short-lived, with no problems with blood clotting.